1,436
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Curative treatment with extracts of Bombax ceiba fruit reduces risk of calcium oxalate urolithiasis in rats

&
Pages 310-317 | Received 07 Dec 2010, Accepted 17 Jun 2011, Published online: 10 Feb 2012

References

  • Adhirai M, Selvam R. (1997). Vitamin E pretreatment prevents cyclosporine A-induced crystal deposition in hyperoxaluric rats. Nephron, 75, 77–81.
  • Anand R, Patnaik GK, Kulshrestha DK, Dhawan BN. (1991). Antiurolithiatic and diuretic activity of lupeol. Proceedings of 24th and 25th Pharmacology Society Conference; A-10.
  • Anand R, Patnaik GK, Kulshrestha DK, Dhawan BN. (1992). Antiurolithiatic and diuretic activity of lupeol, the active constituent isolated from Crataeva nurvala (Buch Ham). Indian J Pharmacol, 24, 48–49.
  • Anonymous. (2001). OECD series on testing and assessment, Number 24. Guidance document on acute oral toxicity testing. ENV/JM/MONO(2001)4. Paris: Environment directorate, OECD.
  • Atmani F, Slimani Y, Mimouni M, Hacht B. (2003). Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. bju Int, 92, 137–140.
  • Balaji KC, Menon M. (1997). Mechanism of stone formation. Urol Clin North Am, 24, 1–11.
  • Baskar R, Malini MM, Varalakshmi P, Balakrishna K, Bhimarao R. (1996). Effect of lupeol isolated from Crataeva nurvala stem bark against free radical-induced toxicity in experimental urolithiasis. Fitoterapia, 67, 121–125.
  • Begun FP, Knoll CE, Gottlieb M, Lawson RK. (1991). Chronic effects of focused electrohydraulic shock waves on renal function and hypertension. J Urol, 145, 635–639.
  • Bijikurien T, Selvam R. (1987). Induction of lipid peroxidation by oxalate in experimental rat urolithiasis. J Biosci, 12, 367–373.
  • Bühler H, Perschel FH, Hierholzer K. (1991). Inhibition of rat renal 11 beta-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids; structure/function relationship. Biochim Biophys Acta, 1075, 206–212.
  • Caraway WT. (1963). Uric acid. In: Seligson D, ed. Standard Methods Clinical Chemistry. New York and London: Academic Press, 4, 239.
  • Chow FC, Dysart MI, Hamar DW, Udall RH. (1975). Control of oxalate urolithiasis by DL-alanine. Invest Urol, 13, 113–116.
  • Dar A, Faizi S, Naqvi S, Roome T, Zikr-ur-Rehman S, Ali M, Firdous S, Moin ST. (2005). Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship. Biol Pharm Bull, 28, 596–600.
  • Denstedt JD, Singal RK. (1997). Contemporary management of ureteral stones. Urol Clin North Am, 24, 68.
  • Ernster L, Nordenbrand K. (1967). Oxidation and phosphorylation. In: Ronald WE, Maynard EP, eds. Methods in Enzymology.Vol. X. New York: Academic Press; 574–580.
  • Fiske CH, Subbarow Y. (1925). The colorimetric determination of phosphate. J Biol Chem, 66, 375–381.
  • Gadge NB, Jalalpure SS, Pawase KB. (2009). Preliminary phytochemical screening and diuretic activity of Bombax ceiba L. fruit extracts. Pharmacologyonline, 3, 188–194.
  • Ghodkar PB. (1994). Chemical tests in kidney disease. In: Textbook of Medical Laboratory Technology. 1st ed. Mumbai: Bhalani Publishing House; 118–132.
  • Gopal H, Gupta RK. (1972). Chemical constituents of Salmalia malabarica Schott and Endl. flowers. J Pharm Sci, 61, 807–808.
  • Hodgkinson A, Williams A. (1972). An improved colorimetric procedure for urine oxalate. Clin Chim Acta, 36, 127–132.
  • Huang HS, Ma MC, Chen J, Chen CF. (2002). Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol, 167, 2584–2593.
  • Kapoor LD. (1990). Handbook of Ayurvedic Medicinal Plants. Boca Raton: CRC Press.
  • Khandelwal KR. (2002). Practical Pharmacognosy, Techniques and Experiments. 9th ed. Pune: Nirali Prakashan.
  • Kirtikar KR, Basu BD. (1980). Indian Medicinal Plants. 2nd ed., Vol. I. Dehradun: International Book Distributors.
  • Krishnamurthy MS, Hruska KA, Chandhoke PS. (2003). The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol, 169, 2030–2033.
  • Lemann J Jr, Worcestor EM, Gray RW. (1991). Hypercalciuria and stones. Am J Kidney Dis, 27, 386–391.
  • Malini MM, Baskar R, Varalakshmi P. (1995). Effect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats. Jpn J Med Sci Biol, 48, 211–220.
  • Mehra PN, Karnick CR. (1968). Pharmacognostic studies on Bombax ceiba Linn. Indian J Pharm, 30, 284
  • Misra MB, Mishra SS, Misra RK. (1968). Pharmacology of Bombax malabaricum (DC). Indian J Pharm, 30, 165–166.
  • Mitra SK, Gopumadhavan S, Venkataranganna MV, Sundaram R. (1998). Effect of cystone, a herbal formulation, on glycolic acid-induced urolithiasis. Phytotherap Res, 12, 372–374.
  • Mukherjee J, Roy B. (1971). Chemical examination of Salmalia malabarica Schott Endl. (syn. Bombax malabaricum DC.). J Indian Chem Soc, 48, 769–770.
  • Mukherjee T, Bhalla N, Aulakh GS, Jain HC. (1984). Herbal drugs for urinary stones – Literature appraisal. Indian Drugs, 21, 224–228.
  • Mustafa MA, Medeiros DM. (1985). Proximate composition, mineral content and fatty acids of cat fish (Ictalurus punctatus rafinesque) for different seasons and cooking methods. J Food Sci, 50, 585–588.
  • Muthukumar A, Selvam R. (1997). Effect of depletion of reduced glutathione and its supplementation by glutathione monoester on renal oxalate retention in hyperoxaluria. J Nutr Biochem, 8, 445–450.
  • Nadkarni AK, Nadkarni KM. (1976). Indian Materia Medica. 3rd ed., Vol. I. Popular Book Depot: Bombay.
  • Namsa ND, Tag H, Mandal M, Kalita P, Das AK. (2009). An ethnobotanical study of traditional anti-inflammatory plants used by the Lohit community of Arunachal Pradesh, India. J Ethnopharmacol, 125, 234–245.
  • Prien EL, Prien EL Jr. (1968). Composition and structure of urinary stone. Am J Med, 45, 654–672.
  • Raghuramulu N, Madhavan NK, Kalyanasundaram S.(1983). In: A Manual of Laboratory Techniques. 1st ed. Hyderabad: National Institute of Nutrition; 34.
  • Richardson TKE, Tolbert NE. (1961). Oxidation of glycolic acid to oxalic acid by glycolic acid oxidase. J Biol Chem, 57, 816–882.
  • Rivers K, Shetty S, Menon M. (2000). When and how to evaluate a patient with nephrolithiasis. Urol Clin North Am, 27, 203–213.
  • Robertson WG, Peacock M. (1980). The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron, 26, 105–110.
  • Robertson WG. (1999). A simplified procedure for assessing the biochemical risk of forming stones in patients with uric acid or calcium containing urinary calculi. In: Borghi L, Mesehi T, Briganti A, eds. Kidney Stones&lt. Cosenza, Italy: Editoriale Bios; 403–406.
  • Roger K, Low MD, Stoller ML. (1997). Uric acid nephrolithiasis. Urol Clin North Am, 24, 135–148.
  • Saleem R, Ahmad M, Hussain SA, Qazi AM, Ahmad SI, Qazi MH, Ali M, Faizi S, Akhtar S, Husnain SN. (1999). Hypotensive, hypoglycaemic and toxicological studies on the flavonol C-glycoside shamimin from Bombax ceiba. Planta Med, 65, 331–334.
  • Saravanan N, Senthil D, Varalakshmi P. (1995). Effect of L-cysteine on lipid peroxidation in experimental urolithiatic rats. Pharmacol Res, 32, 165–169.
  • Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V, Sathish Kumar AS. (2001). Effect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res, 43, 89–93.
  • Seshadri V, Batta AK, Rangaswamy S. (1971). Phenolic components of Bombax malabaricum (Root-Bark). Curr Sci, 40, 630–631.
  • Seshadri V, Batta AK, Rangaswamy S. (1973). Phenolic components of Bombax malabaricum. Indian J Chem, 11, 825
  • Singh D, Chopra K. (2004). The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol Res, 50, 187–193.
  • Sumathi R, Jayanthi S, Kalpanadevi V, Varalakshmi P. (1993). Effect of DL alpha-lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharmacol Res, 27, 309–318.
  • Tisselius HG. (1996). Solution chemistry of supersaturation. In: Coe Fl Favus, MJ, Pak CYC, Parks JH, Preminger GM, eds. Kidney Stones: Medical and Surgical Management. Philadelphia: Lippincott Reven; 33.
  • Vidya L, Varalakshmi P. (2000). Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria. Fitoterapia, 71, 535–543.
  • Vieira TO, Said A, Aboutabl E, Azzam M, Creczynski-Pasa TB. (2009). Antioxidant activity of methanolic extract of Bombax ceiba. Redox Rep, 14, 41–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.